Join us at the 3rd MPN Spring Symposium 2023, an annual international conference dedicated to elevating the quality of life for MPN patients. This dynamic two-day event is your gateway to invaluable insights from 6 world-renowned MPN specialists.
Discover their profiles and expertise in this article, as they lead enlightening keynotes, and presentations.
Prof. Martin Ellis
Director, Blood Bank, Senior Physician-Hematology Institute | Meir Medical Center Chairman, Israel Society of Hematology and Transfusion Medicine. He has made a large amount of publications of his work and is successfully active in research regarding MPN diseases.
Prof. Haifa Kathrin Al-Ali
Senior physician at the University Clinic for Internal Medicine IV. Her clinical focus includes the treatment of patients with acute and chronic malignant myeloid diseases [myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML)]. The scientific focus of her work is the implementation of clinical studies and the investigation of the relevance of genetic and epigenetic changes in malignant myeloid diseases.
Prof. Heinz Gisslinger
Professor at the Medical University of Vienna. He is Program Director for Myeloproliferative Neoplasms at the Medical University of Vienna, specialized in Haematology. His clinical interests are Chronic Myeloid Leukemia Thrombophilia, Multiple Myeloma, Polycythemia, Osteomyelofibrosis, Essential Thrombocythemia, Acute Myeloid Leukemia. He is a pioneer regarding Interferon and he has been doing very important research work in MPN and without his dedication during decades in this field, we would not know as much as we do know nowadays.
Prof. J. J. Kiladjian
Jean-Jacques Kiladjian, MD, PhD, Clinical Pharmacology Hematoogist Saint-Louis Hospital, Paris, France. He is one of the leading researcher in our MPN world.
Prof. Veronika Buxhofer-Ausch
Senior Physician at the Ordensklinikum Linz, Specialist in internal medicine, hematology and oncology with a focus on myeloproliferative diseases.
Prof. Srdan Verstovsek
Professor of medicine and hematologist-oncologist at MD Anderson, is a global leader in myeloproliferative neoplasms (MPN). As the founder and director of the largest MPN Clinical Research Center worldwide, Dr. Verstovsek led many different important phases of trials for emerging MPN medications and published more than 600 peer-reviewed pieces/articles in leading medical journals.
PV patient and Chairwomen of MPN Austria Support Group.
Join us for free, engage with the finest in the field, and get your questions answered!